Terry Vance

Co-Founder at EGS Healthcare Capital Partners LLC

Terry Vance

Terry Vance

Co-Founder at EGS Healthcare Capital Partners LLC

Overview
Career Highlights

Sapvax LLC
EGS Healthcare Capital Partners LLC
Eagle Strategic Advisers LLC

RelSci Relationships

3097

Number of Boards

9

Birthday

1957

Age

63

Contact Data
Trying to get in touch with Terry Vance? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Terry Vance likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman & Chief Executive Officer at Endius, Inc.

Relationship likelihood: Strong

Managing Partner, Chief Operating Officer at LR Management Company LLC

Relationship likelihood: Strong

Co-Founder at BioVentures Investors

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Enanta Pharmaceuticals, Inc.

Relationship likelihood: Strong

Advisor at Mountain Group Capital LLC

Relationship likelihood: Strong

Chief Financial Officer at Epirium Bio, Inc.

Relationship likelihood: Strong

Advisor at Mountain Group Capital LLC

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Chief Executive Officer, Asia Pacific at Asurion LLC

Relationship likelihood: Strong

Advisor at Mountain Group Capital LLC

Relationship likelihood: Strong

Paths to Terry Vance
Potential Connections via
Relationship Science
You
Terry Vance
Co-Founder at EGS Healthcare Capital Partners LLC
Education
BA Unknown

Princeton University is a vibrant community of scholarship and learning that stands in the nation's service and in the service of all nations. Chartered in 1746, Princeton is the fourth-oldest college in the United States. Princeton is an independent, coeducational, nondenominational institution that provides undergraduate and graduate instruction in the humanities, social sciences, natural sciences and engineering. As a world-renowned research university, Princeton seeks to achieve the highest levels of distinction in the discovery and transmission of knowledge and understanding. At the same time, Princeton is distinctive among research universities in its commitment to undergraduate teaching. Today, more than 1,100 faculty members instruct approximately 5,000 undergraduate students and 2,500 graduate students. The University's generous financial aid program ensures that talented students from all economic backgrounds can afford a Princeton education.

MBA

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Career History
Co-Founder
1999 - Current

EGS Healthcare Capital Partners invests in late-stage private and emerging public healthcare companies with promising commercial products that are either on the market or in late stages of development

Advisor
Prior

Mountain Group Partners (“MGP”) is an investor dedicated to investing in and actively guiding transformational businesses in the Life Sciences and Technology sectors. Founded in 2002, MGP principals have invested in more than 30 companies in these sectors.Currently, MGP is investing funds from (1) MGC Venture Partners 2013, LP, (2) Limestone Fund, a fund chosen in 2009 by the State of Tennessee to invest state funds to drive economic growth in Tennessee, and (3) private capital accounts.Mountain Group Partners seeks to invest in seed and early stage companies focused on two major sectors: Life Sciences and Technology. Within the Life Sciences sector, the Fund primarily focuses on investments in the diagnostics, medical device, and nutraceuticals & expedited drug development sub-sectors. Within the Technology sector, the Fund has a concentration in healthcare technology, business services and consumer technology companiesMountain Group Partners seeks to invest in Small/Middle Market Companies ?MGP targets private businesses or divisions of companies typically with revenue between $1 million and $10 million•History of Cash Flow ?Acquisition candidates should have a history of strong cash flow•Quality Management Teams ?MGP seeks to partner with strong management teams that have a proven record of success and who wish to become co-owners with MGP•Basic Industries ?Manufacturing, distribution and basic service companies with strong market shares in focused niches are targeted.

Vice President-Capital Markets Division
Prior

Goldman, Sachs & Co. (GS&Co.), a limited partnership registered as a U.S. broker-dealer and futures commission merchant, together with its consolidated subsidiaries (collectively, the firm), is an indirectly wholly owned subsidiary of The Goldman Sachs Group, Inc. (Group Inc.), a Delaware corporation. The firm is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.

Boards & Committees
Member, Board of Directors
2011 - Current

Enanta Pharmaceuticals, Inc. operates as a biotechnology company. It engages in the research and development of molecule drugs for the treatment of viral infections and liver diseases. The firm offers the medicine under the brands Mavyret and Viekira Pak. The company was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Director
Current

Endius, Inc. develops spine surgery products, implants and techniques to treat spine diseases. The company was founded in 1992 and is headquartered in Plainville, MA.

Member, Advisory Board
Current

Mountain Group Partners (“MGP”) is an investor dedicated to investing in and actively guiding transformational businesses in the Life Sciences and Technology sectors. Founded in 2002, MGP principals have invested in more than 30 companies in these sectors.Currently, MGP is investing funds from (1) MGC Venture Partners 2013, LP, (2) Limestone Fund, a fund chosen in 2009 by the State of Tennessee to invest state funds to drive economic growth in Tennessee, and (3) private capital accounts.Mountain Group Partners seeks to invest in seed and early stage companies focused on two major sectors: Life Sciences and Technology. Within the Life Sciences sector, the Fund primarily focuses on investments in the diagnostics, medical device, and nutraceuticals & expedited drug development sub-sectors. Within the Technology sector, the Fund has a concentration in healthcare technology, business services and consumer technology companiesMountain Group Partners seeks to invest in Small/Middle Market Companies ?MGP targets private businesses or divisions of companies typically with revenue between $1 million and $10 million•History of Cash Flow ?Acquisition candidates should have a history of strong cash flow•Quality Management Teams ?MGP seeks to partner with strong management teams that have a proven record of success and who wish to become co-owners with MGP•Basic Industries ?Manufacturing, distribution and basic service companies with strong market shares in focused niches are targeted.

Transactions
Details Hidden

BioMotiv LLC raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Terry Vance. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Terry Vance's profile does not indicate a business or promotional relationship of any kind between RelSci and Terry Vance.